stella
beta
Exploring the Mechanism of Primary Resistance to Third-generation EGFR-TKIs as First-line Treatment in EGFR-positive Advanced NSCLC (PRECISE Study) — Stella
Recruiting
Back to Lung Cancer, Non-small Cell trials
Trial locations
(1 site)
China
Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, Hunan
View full record on ClinicalTrials.gov